Search
Powered By HealthLine
Special Offers
Health Tools
 Heart Healthy Diet
 Ideal Body Weight Calculator
 Diet Reviews
 Fitness and Family
 Quiz: Test Your Fitness IQ
 Exercise and Fitness Guide
 Eat Out Smart
 Healthy Cooking
 BMI Calculator
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Psychiatric Drugs Might Raise Cardiac Death Risk


Related Encyclopedia
 border=
Acne
Alzheimer's Disease
Aneurysms
Angina Pectoris
More...

Related Healthscout Videos
 border=
Custom Ankle Replacements
Shutting Down Tremor.
Disaster Heart Attacks
Teaching Old Docs New Tricks
More...

Related Animations
 border=
Alzheimer's Disease Video Animation
Angioplasty
Coronary Bypass Surgery
Erectile Dysfunction
More...

Related Drug Information
 border=
Accupril
Actonel
Adderal XR
Altace
More...

Related News Articles
 border=
Drugs Provide Same Benefit as Angioplasty for Diabetics, at Lower Cost
Study: Migraine Raises Risk of Stroke
Link Between Alzheimer's and Heart Failure
Study: Phthalate Exposure Impacts Boys
More...


Page:  << Prev | 1 | 2

Almost 11 percent of those who suffered sudden cardiac death took antipsychotics, compared to 1.4 percent of those who survived heart attacks. The numbers for antidepressants were 7.4 percent and 3 percent, respectively, and 18.4 percent and 5 percent for benzodiazepines, which include drugs such as Xanax.

Those who survived heart attacks were more likely to take aspirin and the heart drugs known as beta blockers.

The findings "are interesting, even provocative, but much more work remains to be done in order to have a high degree of confidence in the results," said Dr. Robert A. Harrington, director of the Duke Clinical Research Institute in Durham, N.C.

Text Continues Below



"For now, society should insist upon randomized clinical trials during and after the drug approval process that test therapies in patients who will likely take the drugs in 'real life,'" Harrington said.

That means those who take part in tests of drugs represent those who ultimately take them when it comes to their medical conditions and the other drugs that they're taking, he explained.

More information

Learn more about sudden cardiac death from the American Heart Association.

Page:  << Prev | 1 | 2

Copyright © 2009 ScoutNews, LLC. All rights reserved.
Last updated 5/14/2009

Related Links
 border=
From Healthscout's partner site on heart disease, MyHeartCentral.com
Learn about heart disease symptoms.
Get more information on heart disease treatment for your health!
What can you do to prevent heart disease? Prevention details here.





SOURCES: Jussi Honkola, M.D., researcher, University of Oulu, Finland; Robert A. Harrington, M.D., professor, medicine, Division of Cardiology, and director, Duke Clinical Research Institute, Durham, N.C.; May 14, 2009, presentation, Heart Rhythm Society annual meeting, Boston


About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy: Updated as of April 1, 2009  Terms of Service   Site Map
Advertising Policy